CAS RN: 2065-04-5
N-[3-(2-Bromo-acetyl)-phenyl]-methanesulfonamide
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 1g
Available purity: ≥95%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 2065-04-5
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
1g
≥95%
0
Out of Stock
Shanghai
Inquiry
2065-04-5 / N-[3-(2-bromoacetyl)phenyl]methanesulfonamide
Standard CAS: 2065-04-5
Multi CAS: No
Basic Information
copy
CAS
2065-04-5 copy
Multi CAS
No copy
Molecular Formula
C9H10BrNO3S copy
Molecular Weight
292.150000 copy
Exact Mass
290.956480 copy
SMILES
CS(=O)(=O)NC1=CC=CC(=C1)C(=O)CBr copy
InChI
InChI=1S/C9H10BrNO3S/c1-15(13,14)11-8-4-2-3-7(5-8)9(12)6-10/h2-5,11H,6H2,1H3 copy
InChIKey
CPSLFLKTEZYTER-UHFFFAOYSA-N copy
Computed Properties
copy
Structural Parameters
Heavy atom count
15 copy
Aromatic heavy atom count
6 copy
Fraction Csp3
0.22 copy
Rotatable bonds
4 copy
H-bond acceptors
3 copy
H-bond donors
1 copy
Molar refractivity
63.03 copy
TPSA
63.24 copy
LogP / Solubility
WLOGP
1.64 copy
MLOGP
1.45 copy
XLogP3
2.4 copy
Consensus LogP
1.83 copy
Log S (ESOL)
-2.71 copy
Class (ESOL)
Moderately soluble copy
Log S (Ali)
-3.14 copy
Class (Ali)
Poorly soluble copy
Log S (SILICOS-IT)
-3.4 copy
Class (SILICOS-IT)
Poorly soluble copy
ADME
GI absorption
High copy
BBB permeant
Yes copy
P-gp substrate
No copy
CYP1A2 inhibitor
No copy
CYP2C19 inhibitor
No copy
CYP2C9 inhibitor
No copy
CYP2D6 inhibitor
Yes copy
CYP3A4 inhibitor
No copy
Log Kp (skin permeation)
-3.34 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
No copy
Veber
Yes copy
Egan
Yes copy
Muegge
Yes copy
Bioavailability score
0.55 copy
Brenk alerts
1 copy
Leadlikeness
Yes copy
Synthetic Accessibility
1.5 copy